Clinical and angiographic profile of the diabetic patient: one-year follow-up

Related Experiment Video

Updated: Jun 21, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

Marco Serrão1, Andreia Pereira, Nuno Santos

  • 1Departamento de Cardiologia Médico-Cirúrgica, Hospital Central do Funchal, Funchal, Portugal. serrao.marco@gmail.com

Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology
|July 29, 2009
PubMed

Insights

Diabetic patients undergoing percutaneous coronary intervention face higher risks of adverse cardiac events and mortality. Aggressive treatment in diabetes mellitus still results in poor long-term outcomes.

Area of Science:

  • Cardiology
  • Endocrinology
  • Vascular Medicine

Background:

  • Diabetes mellitus significantly increases cardiovascular morbidity and mortality.
  • Diabetic patients often present with complex coronary artery disease.
  • Percutaneous coronary intervention (PCI) is a common revascularization strategy.

Purpose of the Study:

  • To describe the clinical and angiographic profile of diabetic patients undergoing PCI.
  • To evaluate the one-year outcomes of diabetic patients after PCI compared to non-diabetic patients.

Main Methods:

  • Retrospective study of 769 patients (241 diabetic, 528 non-diabetic).
  • Analysis of clinical, demographic, angiographic, and angioplasty data.
  • Assessment of composite endpoint of adverse cardiac events and total mortality at one year.

Main Results:

  • Diabetic patients had higher prevalence of cardiovascular risk factors and complex lesions.
  • More stents, including drug-eluting stents, were implanted in diabetic patients.
  • Diabetic patients experienced significantly higher one-year adverse cardiac events (23.6% vs. 15.9%) and mortality (5.8% vs. 2.3%).

Conclusions:

  • Diabetes mellitus is associated with adverse long-term prognosis despite aggressive PCI and medical management.
  • Diabetic patients undergoing PCI require careful monitoring and potentially tailored therapeutic strategies.
Abstract

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...